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Vibrio cholerae accessory 
colonisation factor AcfC: a 
chemotactic protein with a role in 
hyperinfectivity
Esmeralda Valiente1, Cadi Davies1, Dominic C. Mills1,2, Maria Getino  3, Jennifer M. Ritchie3 & 
Brendan W. Wren  1
Vibrio cholerae O1 El Tor is an aquatic Gram-negative bacterium responsible for the current seventh 
pandemic of the diarrheal disease, cholera. A previous whole-genome analysis on V. cholerae O1 
El Tor strains from the 2010 epidemic in Pakistan showed that all strains contained the V. cholerae 
pathogenicity island-1 and the accessory colonisation gene acfC (VC_0841). Here we show that acfC 
possess an open reading frame of 770 bp encoding a protein with a predicted size of 28 kDa, which 
shares high amino acid similarity with two adhesion proteins found in other enteropathogens, including 
Paa in serotype O45 porcine enteropathogenic Escherichia coli and PEB3 in Campylobacter jejuni. 
Using a defined acfC deletion mutant, we studied the specific role of AcfC in V. cholerae O1 El Tor 
environmental survival, colonisation and virulence in two infection model systems (Galleria mellonella 
and infant rabbits). Our results indicate that AcfC might be a periplasmic sulfate-binding protein that 
affects chemotaxis towards mucin and bacterial infectivity in the infant rabbit model of cholera. Overall, 
our findings suggest that AcfC contributes to the chemotactic response of WT V. cholerae and plays an 
important role in defining the overall distribution of the organism within the intestine.
Vibrio cholerae O1 El Tor is an aquatic, Gram-negative, single flagellated bacterium responsible for the current 
seventh cholera pandemic1. After entering the human body by ingestion of contaminated food or water, bacteria 
migrate towards the surface of the small intestine. Colonisation of the intestine leads to the release of cholera 
toxin (CT) and the development of profuse, watery diarrhoea that is characteristic of the disease. Cholera is treat-
able with oral rehydration therapy, but if left untreated, can quickly lead to severe dehydration, toxic shock, and 
death in less than 24 hours post infection2. Cholera remains an important global health problem, mainly affecting 
areas with poor water sanitation. Each year cholera affects an estimated 3 million people, resulting in over 100,000 
deaths, particularly young children3, causing considerable adverse economic consequences to countries in Asia, 
Africa, Oceania and South America4.
CT and the toxin co-regulated pilus (TCP) are well established as the main virulence factors of V. cholerae5–7. 
CT is responsible for the profuse watery diarrhoea that characterises the disease6 whereas TCP, a type IV pilus, 
is essential for V. cholerae colonisation of the small intestine, as demonstrated in both human volunteers8 and 
animal models9. A myriad of other factors has also been associated with V. cholerae pathogenicity10. Of these, 
motility and chemotaxis have been the subject of considerable study given their proposed role in controlling 
the intestinal localisation of the organism. Historically Freter and colleagues proposed that chemotactic-based 
motility was responsible for the preferential localisation of V. cholerae to the crypts of the distal small intes-
tine10,11. However, recent studies12,13 suggest that the distribution of Vibrio cholerae in the intestine is as a result 
of a complex interplay between motility, chemotaxis and host mucin. Chemotaxis is controlled by numerous 
inner membrane-localised methyl-accepting chemotaxis proteins (MCPs) and soluble chemotaxis proteins11,12. 
However, at the molecular level, the chemotaxis network is incompletely understood. Chemotaxis also has a role 
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in the aquatic environment, where it allows bacteria to find suitable environmental and host surfaces, made, for 
example, of chitin. Chitin - a polymer of N-acetylglucosamine, the second most abundant polymer in nature - is 
present in the exoskeleton of crustaceans and serves as both a carbon source and as a chemoattractant of marine 
Vibrio species14,15.
An important genomic island involved in cholera disease is the V. cholerae pathogenicity island 1 (VPI-1), 
which contains the TCP gene cluster. VPI-1 also possesses a cluster of four accessory colonisation factor (acf) 
genes, designated as acfA, acfB, acfC and acfD16. Both TCP and acf genes are regulated by ToxR, the cholera toxin 
transcriptional activator17. The acf genes in V. cholerae O395 (O1 Classical biotype) appear to be required for 
efficient intestinal mice colonisation and biogenesis of the toxin-associated pilus of V. cholerae. In addition, AcfB 
was shown to be an inner membrane protein that affects motility in V. cholerae O39517. However, in the case of V. 
cholerae O1 El Tor, acf genes do not seem to have a role in virulence.
In August 2010, Pakistan experienced the worst flooding in its recorded history, affecting more than 20 mil-
lion people18, followed by a cholera epidemic19. A genetic analysis of V. cholerae O1 El Tor strains from the floods 
identified two distinct groups, isolated from different geographic regions: Pakistan subclades 1 (PSC-1) (isolates 
from the coastal city of Karachi) and 2 (PSC-2) (in countrywide areas). Amongst other differences, genome 
analyses showed that PSC-2 strains had a frame-shift mutation in acfC introducing several stop codons, whereas 
acfC encoded a full open reading frame in PSC-1 strains19. PSC-1 strains appear to be replacing PSC-2 strains in 
Pakistan (Nick Thomson, Wellcome Trust Sanger Institute, Cambridge, personal communication). In addition, 
comprehensive data base searching revealed that AcfC-like proteins are only found in two other bacterial species, 
which are both enteropathogens (Campylobacter jejuni and Escherichia coli), suggesting a new family of proteins 
that maybe important for survival in the mammalian gut. We therefore hypothesized that the presence of a func-
tional acfC in V. cholerae may confer an advantage to strains in PSC-1 to survive in the environment and/or to 
colonise the human small intestine.
In this work, we investigated the biological role of AcfC in V. cholerae O1 El Tor and found that it might be a 
periplasmic sulfate-binding protein, which affects chemotaxis towards mucin and has a direct impact on bacterial 
hyperinfectivity in the infant rabbit model of disease.
Results
Sequence analysis of AcfC suggests a periplasmic localisation and reveals high identity to PEB3 
and Paa proteins. The V. cholerae acfC is an open reading frame of 770 bp encoding a polypeptide of 256 
amino acids that is predicted to be localised to the periplasm, according to the Protein Subcellular Localization 
Prediction for Gram-negative Bacteria (http://www.csbio.sjtu.edu.cn/bioinf/Cell-PLoc-2/). A protein blast search 
(https://blast.ncbi.nlm.nih.gov) indicated that AcfC protein has high similarity to E. coli Paa and C. jejuni PEB3. 
The amino acid sequences of AcfC, PEB3 and Paa were aligned by ClustalW (Fig. 1a). AcfC has 48,4% identity to 
PEB3 and 47% identity to Paa. After cleavage of the first 24 amino acids, which likely encodes a signal sequence, 
the mature AcfC protein is predicted to have a size of 28 kDa (http://www.uniprot.org/uniprot). We confirmed 
the periplasmic localisation of AcfC by cellular fractionation and western blot with anti-AcfC antibodies (Fig. 1b).
V. cholerae AcfC is a sulfate-binding protein. The presence of lysine- and arginine-rich regions in the 
amino acid sequence suggests AcfC may have sulfate-binding properties. We thus tested the ability of His6-tagged 
Figure 1. (a) Blast alignments of V. cholerae AcfC with similar proteins from enteropathogenic bacteria (Paa 
from E. coli and PEB3 from C. jejuni) using Clustal W software; (b) Detection of V. cholerae AcfC expression 
in the different bacterial cell compartments using anti-AcfC antibodies. M: Page ruler plus pre-stained protein 
ladder (Thermo Fisher Scientific); S: Supernatant fraction; OM: Outer membrane fraction; P: Periplasmic 
fraction; IM: Inner membrane fraction; C: Cytoplasmic fraction; Ctrl: Ni-NTA purified His6-tagged AcfC, used 
as a positive control; (c) ELISA analysis of binding AcfC to different sulfated glycosaminoglycans (heparin 
sulfate and chondroitin sulfate), non-sufated glycosaminoglycan (hyaluronic acid) and type II porcine mucin. 
The values are the means ± standard deviation (n = 3). *p < 0.05, as determined by Tukey’s test.
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AcfC to bind to plastic surfaces coated with sulfated proteins - such as heparin sulfate, chondroitin sulfate and 
porcine mucin type II or the non-sulfated protein hyaluronic acid as a negative control. Using an ELISA assay, 
we found that His6-tagged AcfC bound to both heparin, chondroitin sulfate and mucin, but significantly less to 
hyaluronic acid (Fig. 1c). These results suggest that that AcfC might prefer binding to sulfate-containing proteins 
(Fig. 1c).
AcfC is not involved in Caco-2 or HT-29MTX-E12 cell adhesion. Given that orthologous AcfC pro-
teins are involved in epithelial cell adhesion, we tested if that was also the case for AcfC in V. cholerae. The role of 
AcfC in adhesion of V. cholerae was assayed using Caco-2 cells, a cell line well known to produce comparatively 
low amounts of mucin. The adherence of wild type (S2CHK17 strain) and V. cholerae ΔacfC to Caco-2 cells was 
similar (Fig. 2a). We next repeated the experiment with a previously described mucin hyper-producer cell line, 
HT-29MTX-E12 cells. However, we found no differences in adherence between V. cholerae wild type (S2CHK17 
strain) and V. cholerae ΔacfC (Fig. 2a). These findings indicate that AcfC, unlike its protein homologues (PEB3 
or/and Paa)20,21, is not involved in cell adhesion in the conditions of our experiment.
To confirm this result, we investigated whether recombinant expression of AcfC in a non-adherent E. coli 
strain (LMG194) would be able to alter its’ adhesion properties. In line with our results obtained with V. cholerae, 
expression of His6-tagged AcfC in E. coli LMG194 did not alter adhesion to Caco-2 or HT-29MTX-E12 cells 
compared to the empty vector control (Fig. 2b and c). The positive control strain, E. coli ATCC25922, however 
adhered effectively to Caco-2 cells (10% ± SD) and HT-29MTX-E12 cells (3%±) indicating the validity of the 
assay. Based on these results, we concluded that AcfC is not an adhesion to intestinal cell lines.
Biofilm formation. To survive and colonise both the aquatic environment and the human intestine, V. chol-
erae forms biofilms on different abiotic and biotic surfaces. We thus studied the ability of V. cholerae S2CHK17 
and ΔacfC to form biofilms on 24-well plates with or without mucin and/or chitin. Our results demonstrate that 
the presence of mucin or chitin enhances biofilm formation in both V. cholerae S2CHK17 and ΔacfC. However, 
the absence of AcfC does not affect biofilm formation neither on mucin nor on a chitin surface (Fig. 3a).
Figure 2. (a) Adhesion of V. cholerae S2CHK17 and ΔacfC to Caco-2 and HT-29MTX-E12 cell lines. Adhesion 
of LMG194 and LMG194 with pEXT20-AcfC construct to Caco-2 (b) and HT-29MTX-E12 (c) cell lines. E. coli 
ATCC25922 was used as an adhesion positive control. Each value is the average of three replicates. Error bars 
represent the standard deviation (n = 3). Statistical analyses using the Tukey’s multiple comparisons test showed 
no significant differences in adhesion to cell lines.
Figure 3. V. cholerae S2CHK17 and ΔacfC biofilm formation (a), chemotaxis towards mucin including AcfC 
complement strain and chemotaxis towards chitin (b). The values are the means ± standard deviation (n = 3). 
*p < 0.05, as determined by Tukey’s test.
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AcfC mediates chemotaxis to mucin but not chitin. The initial stages of colonisation of the human 
intestinal epithelium often involve the efficient movement and taxis towards mucin covering epithelial cells. We 
studied bacterial chemotaxis by filling a syringe with the chemoattractant, chitin or mucin, and inserting it into 
a pipette tip containing a bacterial suspension. We found that V. cholerae ΔacfC is significantly less chemotactic 
towards mucin compared to the wild type strain; complementation of the acfC gene restored normal chemotaxis 
(Fig. 3b). However, we found no significant differences in chemotaxis towards chitin between V. cholerae wild 
type and ΔacfC mutant (Fig. 3b). Our results suggest that AcfC is required for chemotaxis towards mucin, but 
does not affect chemotaxis towards chitin.
AcfC deletion does not affect flagellar assembly or motility. To rule out that the attenuated chem-
otactic phenotype in the ΔacfC mutant was not due to a defect on motility or flagella assembly, we measured V. 
cholerae motility and flagellar length. Both wild type V. cholerae and the ΔacfC mutant were similarly motile 
(Fig. 4a) and bacteria of both strains possessed a single polar flagellum (Fig. 4b) of similar length (Fig. 4c), sug-
gesting that AcfC has no direct role in motility or flagellar assembly.
AcfC does not contribute to virulence in Galleria mellonella. G. mellonella larvae have been used 
previously as a simple, invertebrate model to study the virulence of different bacterial pathogens, including V. 
cholerae22. Pathogenic potential, as reflected by larvae mortality, has been found to correlate with virulence estab-
lished using mammalian models for several pathogens23,24. Injection of G. mellonella with 2.6 ± 1.0 × 105 CFU of 
WT or ΔAcfC lead to similar mortality of the wax moth larvae after 24 hours infection (22% versus 24% survival 
in WT and ΔAcfC, respectively; Fig. 4d). Consistent with this finding, the corresponding LD50 of the WT and 
the ΔacfC mutant was 1.1 ± 0.3 × 105 CFU per larvae, respectively. As expected, control larvae injected with PBS 
maintained 100% survival throughout the length of the virulence assay. These results demonstrate that AcfC 
deletion in V. cholerae El Tor has no effect on pathogenesis in the G. mellonella model.
Figure 4. (a) V. cholerae S2CHK17 and ΔacfC motility; (b) TEM pictures; (c) Flagella measurements: The 
flagella length of one hundred bacteria were measured in each strain and TEM images were analysed using the 
line measuring tool of Image J 1.50i software (National Institutes of Health, USA); (d) G. mellonella infection 
results Representative data of survival rate of 3 biological replicates of 10 individual G. mellonella injected with 
2.6 ± 1.0 × 105 CFU of each strain in 10 µl of sterilised PBS and incubated at 37 °C. Survival was assayed by 
response to touch or discoloration. Killing by WT and ΔacfC was observed after 24 h. No killing was observed 
in the PBS injection control for the length of the experiment. Error bars represent the standard deviation 
(n = 3). Statistical analyses using the Tukey’s multiple comparisons test showed no significant differences in V. 
cholerae survival.
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AcfC mutant exhibits increased infectivity and colonisation of the proximal small intestine of 
infant rabbits. To further explore the virulence of the ΔacfC mutant and correlate the response seen in G. 
mellonella larvae to that of a mammalian host, we used the infant rabbit model of cholera25. Oral infection of 
rabbits with ~1 × 109 CFU of WT bacteria caused diarrhoea or intestinal fluid accumulation in ~67% of animals 
(Table 1), similar to that found previously for other V. cholerae O1 El Tor strains25, although this was evident 
by 12 h rather than 18 h post infection. By contrast, the ΔacfC mutant caused watery diarrhoea in all (100%) 
infected rabbits. Furthermore, the rabbits appeared sicker with a trend towards a more rapid and severe infection 
compared to those given WT organisms. While fluid accumulation was evident in the mid to distal regions of the 
small intestine of WT-infected animals, this extended proximally into the upper third of the small intestine of 
animals infected with ΔacfC mutant. Moreover, the cecal fluid accumulation ratio (FAR), a surrogate measure for 
diarrhoea, tended to be greater in rabbits infected with ΔacfC mutant compared to WT (Table 1). Thus, overall 
the ΔacfC mutant appeared to exhibit increased (or hyper) infectivity compared to the WT strain.
Hyperinfectivity of V. cholerae has previously been associated with non-chemotactic smooth swimming 
strains that are better able to colonise the entire length of the small intestine2,11. In order to investigate whether 
enhanced colonisation occurred in rabbits infected with the ΔAcfC mutant, we determined the number of WT 
and ΔacfC mutant bacteria present in tissue homogenates taken from the proximal, mid and distal regions of the 
small intestine, and from the mid colon of infected rabbits. Higher numbers of the ΔacfC mutant were recovered 
in each of the intestinal sections taken from these single strain infected animals, reaching statistically significant 
differences in the proximal (P < 0.01) and mid (P < 0.05) small intestine, and the colon (P < 0.05) (Fig. 5). In the 
tissue samples, ~1 log more bacteria were recovered in acfC-infected rabbits than in those given WT V. cholerae. 
Furthermore, significantly higher numbers of the mutant were recovered in the cecal fluid (WT – 3.6 × 107 CFU/
mL versus ΔacfC mutant 3.6 × 108 CFU/mL; P < 0.05), consistent with the higher burden of V. cholerae present 
in tissue homogenates.
Discussion
In this study, we provide a detailed characterisation of the V. cholerae O1 El Tor accessory colonisation factor, 
AcfC, which might be a sulfate-binding protein that enhances chemotaxis towards intestinal mucin and contrib-
utes to promoting the ‘correct’ localisation of WT V. cholerae in the small intestine. As mucus is rich in sulfated 
molecules26 we hypothesize that AcfC might act as a ‘sulfate sensor’ of V. cholerae O1 El Tor that senses intestinal 
mucus and facilitates penetration of the mucus layer by directing chemotaxis towards sulfated molecules at the 
intestinal surface. The V. cholerae acfC gene is part of a polycistronic operon downstream of acfB in Vibrio path-
ogenicity island I. Moreover, acfB gene is under the control of ToxR-ToxT regulatory cascade and is structurally 
and functionally related to methyl-accepting chemotaxis enteric protein27,28. It has been suggested that V.cholerae 
AcfB and AcfC interaction activates a chemotaxis signal transduction cascade mediated by Che proteins29. It 
has also been reported that AcfB is another accessory colonisation factor, which affects chemotaxis but does not 
affect V. cholerae virulence in mice. This may be due to overlapping or redundant chemotaxis roles with other 
proteins, such as toxin co-regulated pilus (TcpI)28. Two orthologues of AcfC, PEB3 from C. jejuni and Paa from 
porcine-pathogenic E.coli are considered to be adhesins involved in attachment to human epithelial cells26,30. 
However, our work suggests that the primary role of AcfC in V. cholerae is that of a chemotaxis-related protein, 
rather than being directly involved in adhesion to cell lines. AcfC has been also hypothesized to be a secreted 
protein in V. cholerae O395 (O1 El Classical biotype)30. By contrast, we confirmed the periplasmic localisation of 
AcfC in V. cholerae O1 El Tor using cellular fractionation and immunoblotting. In C. jejuni, PEB3 is also known 
to be a periplasmic glycoprotein30.
AcfC mediates chemotaxis towards mucin but does not have a role in mucin or chitin induced biofilm for-
mation. However, other proteins in V. cholerae with a role on chitin induced biofilm formation such as the toxin 
co-regulated pilus, which mediates bacterial interactions during biofilm formation on chitinaceous surfaces have 
been described31.
Motility is necessary for chemotaxis in V. cholerae, but mutants in motility and chemotaxis behave differently 
in vivo12. V. cholerae chemotaxic mutants exhibited enhanced colonisation in infant mice particularly in the prox-
imal intestine13. Our AcfC mutant has an altered chemotaxis phenotype and increased infectivity with enhanced 
Bacterial strain WT ΔacfC
Diarrhoea (%) 67 100
Diarrhoea scorea
Severe 10 19
Mild 2 0
None 6 0
Total no. of animals 18 19
P valueb 0.008
FARc 1.51 ± 0.68 2.09 ± 0.96
P valued 0.09
Table 1. Diarrhoeal status of rabbits infected with wild type V. cholerae or the ΔacfC mutant. aNumber of 
rabbits with diarrhoea as described in the text. bFisher’s exact test was used to compare the number of WT-
infected rabbits with disease versus the ΔacfC mutant. cFluid accumulation ratio (FAR) is calculated from the 
weight of the cecal fluid to the tissue for each animal. dStudents 2-sided T test.
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fluid accumulation in AcfC-infected rabbits comparing to wild-type infected animals. All these data are in accord 
with other non-chemotactic “smooth swimming” mutants which have also increased infectivity11,12. In contrast, 
Kamp and colleagues reported that acf genes in V. cholerae O1 El Tor are not important in pathogenesis, dissem-
ination and transmission32. However, in the study of Kamp et al., they sampled the distal small intestine of infant 
rabbits and did not investigate the other parts of the small intestine, which might explain their contrasting results.
We studied the role of AcfC in virulence by using two in vivo model systems. In our G. mellonella infection 
model, AcfC mutant has no effect on pathogenesis. This insect model may only be suitable for crude virulence 
screening of strains. However, for colonisation studies, an animal model with a more developed intestine would 
be more appropriate, such as the case of the infant rabbit model.
Taken together, this is the first study showing the accessory colonisation factor AcfC of V. cholerae O1 El Tor 
might act as a periplasmic sulfate-binding protein, affecting bacterial chemotaxis towards mucin. Furthermore, 
our results show that AcfC has a significant role in governing V. cholerae distribution in the small intestine of 
infant rabbits. It is intriguing to speculate why PSC-2 strains, which lack a functional acfC gene, are less promi-
nent in the Pakistan cholera outbreak than PSC-1 strains, given that the former may exhibit increased infectivity. 
Perhaps despite their increased infectivity, other genetic or phenotypic differences between the lineages aid sur-
vival outside of the host, an important aspect of the V. cholerae lifecycle.
Methods
Bacterial strains and growth conditions. Strains, plasmids and oligonucleotides used in this study are 
listed in Table 2. Vibrio cholerae S2CHK17 and acfC mutant were routinely grown on Luria agar (LA), broth (LB) 
or thiosulfate citrate bile salts sucrose agar (TCBS) at 37 °C. All cultures were grown from glycerol stocks in aer-
obiosis. Escherichia coli DH5α were used for cloning experiments. E. coli MFD λ-pir was used as a conjugation 
donor. E. coli LMG194 was used as host strain for protein expression. Where appropriate media was supple-
mented with ampicillin (100 μg/ml) or chloramphenicol (30 μg/ml).
Vibrio cholerae cell fractionation and AcfC antibody production. V. cholerae cells were fractionated 
following the protocol as described33. Each protein fraction was run on a Nu-Page 4–12% Bis-Tris SDS-PAGE 
Figure 5. Recovery of WT V. cholerae or the ΔacfC mutant from different regions of the rabbit intestine at 
12 hours post infection. Numbers of CFU recovered from tissue homogenates of different regions of the small 
intestine (SI) or colon. Open symbols represent samples where the number of recovered bacteria is below the 
detection limit (value has been set at detection limit). Bars represent the geometric mean and each data point 
represents an individual animal (WT – 15 rabbits; acfC mutant – 19 rabbits; 3 independent litters used for each 
strain). Data were log transformed and compared using an unpaired 2-tailed Students T test.
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gel and analysed by immunoblotting using anti-AcfC antibodies. Experiments were performed in three sepa-
rate biological replicates and measured as two technical replicates each. AcfC rabbit polyclonal antiserum was 
obtained from CovalAB UK (Cambridge, UK) against the following peptides: CAESFEKSQSKRVNIT and 
CFDYLTKSKDAEAIFQHY.
Expression of C-terminally His6-tagged AcfC in Escherichia coli and Vibrio cholerae. The acfC 
ORF with an optimized ribosomal binding site (RBS) and a C-terminally His6-tag were amplified using primer 
VC0841RBS_EcoRIF and VC0841RBS_XbaI (Table 2) and Phusion polymerase (NEB). The amplicon was cloned 
into pEXT20 using EcoRI and XbaI cloning sites producing pEXT20-acfC. This construct was transformed into 
the expression strain E. coli LMG194 (Invitrogen) and V. cholerae S2CHK17. E. coli or V. cholerae cells were grown 
until the OD600 was 0.5–0.7. Protein expression was induced by adding isopropyl β-D-1-thiogalactopyranoside 
(IPTG) at 1 mM for 3 h and 24 h in E. coli and V. cholerae, respectively. Cultures were centrifuged and pellets 
were stored at −20 °C. Cells were subsequently thawed on ice, lysed and recombinant protein was purified with 
Ni-NTA agarose (QIAGEN). Protein samples were run on a Nu-Page 4–12% Bis-Tris SDS-PAGE gel and analysed 
by immunoblotting using anti-His6 antibodies (Abcam, UK).
Western blot. Proteins were transferred to a nitrocellulose membrane using iBLOT system (Life 
Technologies). A rabbit anti-Histag (ab9108, Abcam,UK) or anti-acfC antibody were used as primary antibodies 
and a fluorescently labelled goat anti-rabbit IR Dye 680RD secondary antibody (Li-cor) was used as secondary 
antibody. The membrane was visualized using an Odyssey fluorescent imager (LI-COR). The un-cropped image 
of Fig. 1b is in Supplementary Figure 1.
Sulfate binding assay. Flat-bottomed 96-well plates were coated with 200 µl of 100 µgml−1 glycosaminogly-
cans (chondroitin sulfate and heparin sulfate), type II porcine mucin (Sigma) and non-glycoaminoglycan (hyalu-
ronic acid), at 4 °C for 18 h. The wells were washed with PBS and blocked with 0.5% bovine serum albumin (BSA) 
for 1 h at 37 °C. The wells were washed and then incubated with 0–200 pmol purified AcfC (in PBS) for 1 h at room 
temperature and then incubated with 200 µl of rabbit anti-AcfC antibodies (1:1000) in 0.1% BSA in PBS for 1 h at 
RT. After several washes, bound AcfC was then incubated with alkaline phosphatase conjugated goat anti-rabbit 
antibody (Sigma, UK) in 0.1% BSA in PBS. Reactions were developed with 50 mM p-nitrophenylphosphate 
(Sigma, UK). The reactions were stopped by adding 3 M NaOH to each well and absorbance at 405 nm was meas-
ured. Coating efficiency of the glycoaminoglycans and non-glycoaminoglycans and porcine mucin used in this 
study, was analyzed by measuring the protein concentration in each well after PBS washes using a Bradford assay. 
Wells without coating were used as negative controls. Experiments were performed in three separate biological 
replicates, measured as three technical replicates each.
Strain, plasmid and 
oligonucleotides Relevant characteristic (s) or sequence (5′ to 3′)
Source or 
reference
Strains
Escherichia coli
   DH5α F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1 Invitrogen
   LMG194 F− ΔlacX74 galE thi rpsL ΔphoA (PvuII) Δara714 leu::Tn10 Invitrogen
   MFD λ-pir MG1655 RP4-2-Tc::[ΔMu1::aac(3)IV-ΔaphA-Δnic35-ΔMu2::zeo] ΔdapA::(erm-pir) ΔrecA 43
   Vibrio cholerae
   S2CHK17 V.cholerae O1 El Tor, isolated from Pakistan 2010 19
   AcfC mutant S2CHK17 ΔAcfC, in frame deletion mutant This study
Plasmids
   pEXT20 Expression vector, Ampr, IPTG-inducible 38
   pDS132 Suicide plasmid, Cnr 35
   pEXT20-AcfC pEXT20 with optimized RBS and AcfC open reading frame (xxxbp) This study
   pDS132-acfC pDS132 with SOE PCR fragment (xxxbp) This study
Oligonucleotides
   VC0841A-SacI AAGAGCTCTAATGCTGAAGCCATTGCATC This study
   VC0841B TGTACTCTCCCTAAAATCACTTAAATGATAAACTTACTGATTAAATCATC This study
   VC0841C GTGATTTTAGGGAGAGTACATGTACTC This study
   VC0841D-SacI TTGAGCTCATCTGCTTAACTTTGGTAACTGG This study
   Internal primer F TACAAATTGTTGATATCACAAATCAAGTAG This study
   Internal primer R CAAAATAAAATAGTAATGCAAAGTGATAAAG This study
   VC0841RBS_EcoRIF AAGAATTCAGGAGGTAAAACATATGTATTTCATGAAAAGTAAGAATCG This study
   VC0841RBS_XbaIR TTTCTAGATCAATGATGATGATGATGATGCTTAAACCAGCCATAGTGCT This study
Table 2. Strains, plasmids and oligonucleotides used in this study.
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Allelic exchange mutagenesis and complementation. In-frame deletion mutants were constructed 
using the splicing by overlap extension (SOE) PCR and allelic exchange34. We used the V. cholerae S2CHK17 
genome sequence as a template. Primers are listed in Table 2. The SOE PCR fragment was cloned into the suicide 
vector pDS13235 and electroporated into the E. coli MFD λ-pir strain (a diaminopemilic acid (DAP) auxotroph) 
and then conjugated into V. cholerae λ-pir via cross streaking on LB plates containing 0.3 mM diaminopimelic 
acid (DAP). Growth from these plates was then transferred to LB plates containing 30 μg/ml chloramphenicol to 
select for V. cholerae with the suicide vector only. Double-crossover deletion mutants were then screened by PCR 
using flanking primers (Table 2) and confirmed by colony PCR and sequencing. The complemented strain was 
made by electroporation (1.8 kV) of the pEXT20-acfC construct to acfC mutant strain. The complemented strain 
was grown in LB with the corresponding antibiotic and 1 mM IPTG induction for 24 h.
Cell adhesion to Caco-2 and HT-29MTX-E12 mucus secreting cell lines. The low mucin producer, 
human Caco-2 colon adenocarcinoma cell line36 was obtained from the National Type Culture Collection. The 
human HT-29MTX-E12 mucus secreting cell line37 was obtained from Sigma, UK. The cells were maintained in 
Gibco RPMI 1640 (Life technologies, USA) or Dulbecco’s modified Eagle’s high glucose medium (Sigma-Aldrich, 
UK) respectively, both supplemented with 10% (v/v) fetal calf serum, 1% (v/v) non-essential amino acids and 
1% (v/v) penicillin-streptomycin (Sigma-Aldrich) in a 5% CO2 humidified atmosphere at 37 °C. Escherichia coli 
LMG194 and V. cholerae were grown in LA from a glycerol stock for 20 h at 37 °C and then LB was inoculated with 
a single colony and grown 20 h at 37 °C. A secondary culture was inoculated, and protein expression was induced 
by adding IPTG 1 mM for 24 h at 37 °C.
For adhesion assay, medium was replaced with 1 ml of 1 × 108 CFU/ml of E. coli LMG194 or V. cholerae sus-
pended in the previously described antibiotic free tissue culture media (human Caco-2 colon adenocarcinoma 
and HT-29MTX-E12 mucus secreting cell line with Gibco RPMI 1640 (Life technologies, USA) or Dulbecco’s 
modified Eagle’s high glucose medium (Sigma-Aldrich, UK) respectively, both with 1% (v/v) fetal calf serum 
and 1% (v/v) non-essential amino acids). The adhesion assay was performed for 2 h. In parallel, we grew E.coli 
and V. cholerae in the antibiotic free tissue culture media we used for the adhesion assay (described above) and 
checked AcfC expression after 2 h and we were able to detect AcfC expression in V. cholerae wild type and E.coli 
with pEXT20-AcfC construct. This could be due to the pTac promoter on the medium copy pEXT20 vector which 
does lead to leakiness38. However, we did not detect AcfC expression in the acfC mutant or pEXT20 empty vector.
For adhesion assays, the medium was replaced with antibiotic free medium supplemented with 1% (v/v) fetal 
calf serum and 1% (v/v) non-essential amino acids 24 hours prior to experiments. Both cell lines were seeded at 
2.5 × 105 cells/ml into 24-well plates (Corning Glass Works, Netherlands) using 1 ml of cell suspension per well.
Adhesion assays were performed on Caco2 or HT-29MTX-E12 monolayers that had reached 80–90% con-
fluence in 24-well plates. Infections were carried out for 2 h. For infections, medium was replaced with 1 ml of 
1 × 108 CFU/ml of E. coli LMG194 or V. cholerae suspended in the previously described antibiotic free tissue 
culture media. After co-incubation, the monolayers were washed 3 times with 1 ml of PBS 1X and incubated 
with 200 µl of 0.25% trypsin EDTA to break up the monolayer which was subsequently diluted and plated onto 
LB agar with or without corresponding antibiotic to calculate CFU/ml. E. coli ATCC25922 was used as adhesion 
positive control. Experiments were performed in three separate biological replicates, measured as three technical 
replicates each.
Motility and electron microscopy (EM). Bacteria were grown on LA plates for 24 h, at 37 °C. One colony 
was inoculated in LB with 0.3% agar (BD Bacto-agar) and incubated at 37 °C for 18 h. Photographs were captured 
after the incubation time with a Canon 600D SLR. The diameter of the halo was also determined. Experiments 
were performed in three separate biological replicates, measured as three technical replicates each.
For V. cholerae visualization by EM, strains were grown in LB tubes at 37 °C, overnight under aerobic condi-
tions. Each strain was grown in a total volume of 1 ml and was incubated for 18 h. 500 µl of 2.5% paraformalde-
hide/2.5% glutaraldehyde/0.1 M Na cacodylate pH 7.4 was added to 500 µl of the bacterial culture. Five ml were 
placed onto a platform coated 300 mesh copper grid for 1 min. The sample was then stained with 10 µl of 0.3% 
phosphotungstic acid (PTA) pH 7 for 1 min. The PTA was drained and the grid was air-dried before examining 
on the Jeol 1200EX Transmission Electron Microscope. Digital images were recorded using a side-mounted AMT 
2K CCD Digital camera supplied by Deben UK Ltd, IP30 9QS.
Chemotaxis towards mucin and chitin. Chitin (Sigma, UK) and Type II mucin from porcine stomach 
(Sigma, UK) was prepared freshly for each assay by suspending at 2% (wt/vol) in chemotaxis buffer (sterile PBS 
1X with 0.01 mM filter sterilised EDTA). V. cholerae cells were grown to an OD600 of between 0.4 and 0.6 in LB 
broth. Chemotaxis was measured following the protocol as described39. Results were compared to control needles 
containing only chemotaxis buffer to determine the chemotaxis response. The chemotaxis response was calcu-
lated as the ratio of test CFU/ml to control CFU/ml. Comparisons were made between strains using at least three 
biological assays containing two technical replicates each.
Biofilm formation. V. cholerae strains were grown in Marine Sea Water Yeast Extract (MSWYE) agar and 
broth40 overnight at 37 °C. Two ml of culture was inoculated into low evaporation 24-well plates at 1:200 dilu-
tion. The cultures were grown statically for one day after which the supernatant was carefully removed and the 
wells washed with 1 ml of PBS 1X. Each well was incubated with 1% crystal violet (wt/v) at room temperature for 
20 min. The crystal violet was dissolved with methanol for 15 min at room temperature. The OD595 was measured 
in a Spectrophotometer (Biotek, UK). Experiments were performed in three separate biological replicates, meas-
ured as three technical replicates each.
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Galleria mellonella virulence assay. This assay was performed as previously described41,42 using a 
micro-injection technique whereby 10 µl V. cholerae was injected into the haemocoel via the right foreleg, using 
a Hamilton syringe. G. mellonella larvae were bred in sterile conditions at 37 °C. After injection of bacteria, cat-
erpillars were incubated at 37 °C and survival and macroscopic appearance were recorded at 24 h post-infection. 
Caterpillars were considered dead when they were nonresponsive to touch. Three biological replicates of ten 
individual G. mellonella were performed.
Infant rabbit infections. All experimental protocols were approved by the local Animal Welfare and Ethical 
Review Body, the Home Office and carried out in accordance with the UK Animals (Scientific Procedures) Act 
1986.
Adult New Zealand White females were obtained from a commercial breeder (Harlan Laboratories, UK) and 
time-mated when required to produce litters of infant rabbits. Individual litters, typically containing 6–8 pups, 
were housed as a group in a nest box with the lactating doe for the duration of the experiments. Experiments 
were performed generally as described previously25. Briefly, two- to three day old infant rabbits were treated with 
ranitidine hydrochloride (GlaxoSmithKline) by intraperitoneal injection (2 mg/kg bodyweight) 2 hours prior to 
infection. Bacteria were given orally by gavage using a Size 5 French catheter (Arrow International). Infant rab-
bits were infected with ~1 × 109 CFU WT V. cholerae or the ΔacfC mutant. The inoculum was prepared from 
stationary phase (18 h) cultures of the bacteria grown in LB broth supplemented with 100 µg/mL streptomycin 
at 37 °C with shaking (250 rpm). To prepare the inoculum, bacterial cultures were centrifuged (5 min, 8 rpm) to 
pellet the cells and the supernatant was removed. Cell pellets were resuspended in sodium bicarbonate solution 
(2.5 g in 100 mL; pH 9) adjusted to yield a final cell density of ~2 × 109 CFU/mL. Diarrhoea was scored using the 
following scale: none (rabbits were dry with no signs of faecal contamination or wetness on their ventral surfaces; 
upon dissection, the colon contained digesta that appeared normal (dark green, hard and formed)); mild (soft 
yellow stools and/or limited areas of wetness were evident on the rabbits’ fur; upon dissection, digesta was missing 
from the colon or appeared yellow, soft and unformed), and severe (rabbits exhibited extensive areas of wetness 
on their tails’ and ventral surfaces; upon dissection no digesta was found in the colon and the cecum and small 
intestine contained large quantities of clear fluid). Infant rabbits were anesthetized with inhalational isoflurane 
prior to euthanasia by cervical dislocation.
At euthanasia, intestinal samples and cecal fluid were collected as described previously25. The number of V. 
cholerae CFU in tissue samples was determined after homogenisation in PBS by plating on LB supplemented with 
100 µg/mL streptomycin. The detection limit of the assays was ~100 CFU/g. Rabbits, which contained no WT V. 
cholerae colonies in any of the intestinal samples were considered ‘uncolonised’ and excluded from subsequent 
analysis; the reasons why we fail to recover any colonies in a small number (<1 in 10) of rabbits orally-infected 
with wild type bacteria are unknown. However, rabbits, in which viable V. cholerae were detected in at least one 
intestinal sample, were included in order to capture the natural variation of colonisation and disease that occurs 
in this host. In these animals, samples that yielded no bacteria at the lowest dilution tested were included in the 
calculation of the mean values presented in Fig. 5 by using the lower limit of detection as a value.
Statistical analysis. Data were expressed as mean ± standard deviation. The statistical test used was Tukey’s 
multiple comparisons test using Prism software 9 version 4.0 (GraphPad Software, Inc, San Diego, CA). p > 0.05 
was considered statistically significant. The diarrhoeal state of the rabbits were compared using Fisher’s exact test. 
Cecal fluid accumulation ratios (FARs) and colonisation data (after log transformation) were statistically analysed 
using unpaired 2-sided Student T test (GraphPad Prism, San Diego, CA).
Data availability statement. The datasets generated during and/or analysed during the current study are 
available from the corresponding author on reasonable request.
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